Clinical Trials Directory

Trials / Unknown

UnknownNCT05617950

Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts

Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
174 (estimated)
Sponsor
The 306 Hospital of People's Liberation Army · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

To evaluate whether salicylic acid was superior to cryotherapy for plantar warts

Detailed description

Patients with plantar warts were randomized equally to receive salicylic acid or cryotherapy. Cryotherapy is delivered by a technician up to a maximum of four treatments 3 weeks apart. Thirty percent of salicylic acid is applied once daily by the patient (or parent) for a maximum of 12 weeks. The primary outcomes were the cure rates at 12 weeks; secondary outcomes included time to clearance of warts, patient satisfaction with the treatment and treatment-related adverse effects.

Conditions

Interventions

TypeNameDescription
OTHERsalicylic acidSalicylic acid is applied once daily by the patients (or parents) for a maximum of 12 weeks.
OTHERcryotherapyCryotherapy is delivered by a technician up to a maximum of four treatments 3 weeks apart.

Timeline

Start date
2022-11-01
Primary completion
2022-11-01
Completion
2022-11-01
First posted
2022-11-16
Last updated
2022-11-16

Source: ClinicalTrials.gov record NCT05617950. Inclusion in this directory is not an endorsement.